IP Clinic

Lodz 90752

1 studies enrolling now · 6 studies all time

What they study most

Colitis, Ulcerative, Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Inflammatory Bowel Diseases, Monoclonal Antibody, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC — Running, not enrolling
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis — Completed